The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function
mBio · 28.02.2023 · 14 (1)
DOI: 10.1128/mbio.03560-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 28.02.2023. Verfasst von Matthew R Singer und 14 weiteren Autor:innen. Beteiligte Einrichtung: Chromatin Structure & Mobile DNA Laboratory, The Francis Crick Institute, London, United Kingdom. Hauptthemen laut MEDLINE: HIV Integrase Inhibitors, HIV Infections. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Wellcome Trust, Cancer Research UK.
Abstract (Originalsprache)
Despite the remarkable success of combination antiretroviral therapy, HIV-1 remains among the major causes of human suffering and loss of life in poor and developing nations. To prevail in this drawn-out battle with the pandemic, it is essential to continue developing advanced antiviral agents to fight drug resistant HIV-1 variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chromatin Structure & Mobile DNA Laboratory, The Francis Crick Institute, London, United Kingdom.
- Division of Infectious Diseases, School of Medicine, University of Colorado, Aurora, Colorado, USA.
- Department of Chemistry and Biochemistry, University of Delaware, Newark, Delaware, USA.
- Macromolecular Structure Laboratory, The Francis Crick Institute, London, United Kingdom.
- ST Pharm Co. Ltd., Seoul, South Korea.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
ORCID-Profile: Juan R Perilla, Mamuka Kvaratskhelia, Peter Cherepanov
Förderung
- NIAID NIH HHS
- Wellcome Trust
- Cancer Research UK
- Medical Research Council
- NIGMS NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases
- HHS | NIH | National Institute of General Medical Sciences
Zitieren
APA
Singer, M. R., Dinh, T., Levintov, L., Annamalai, A. S., Rey, J. S., Briganti, L., Cook, N. J., Pye, V. E., Taylor, I. A., Kim, K., Engelman, A. N., Kim, B., Perilla, J. R., Kvaratskhelia, M., & Cherepanov, P. (2023). The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function. mBio, 14(1). https://doi.org/10.1128/mbio.03560-22
Vancouver
Singer MR, Dinh T, Levintov L, Annamalai AS, Rey JS, Briganti L, et al. The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function. mBio. 2023;14(1). doi:10.1128/mbio.03560-22
BibTeX
@article{Singer2023,
author = {Singer, Matthew R and Dinh, Tung and Levintov, Lev and Annamalai, Arun S and Rey, Juan S and Briganti, Lorenzo and Cook, Nicola J and Pye, Valerie E and Taylor, Ian A and Kim, Kyungjin and Engelman, Alan N and Kim, Baek and Perilla, Juan R and Kvaratskhelia, Mamuka and Cherepanov, Peter},
title = {The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function},
journal = {mBio},
year = {2023},
volume = {14},
number = {1},
doi = {10.1128/mbio.03560-22}
}
EUVIMED